Compile Data Set for Download or QSAR

Found 3 hits of ic50 for monomerid = 50101753   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50101753 ((S)-2-(4-Isopropyl-benzenesulfonylamino)-3-({5-[2-...) Show SMILES CC(C)c1ccc(cc1)S(=O)(=O)N[C@@H](CNC(=O)c1ccc(CCC(=O)NC2=NCCCN2)s1)C(O)=O |t:28| Show InChI InChI=1S/C24H31N5O6S2/c1-15(2)16-4-8-18(9-5-16)37(34,35)29-19(23(32)33)14-27-22(31)20-10-6-17(36-20)7-11-21(30)28-24-25-12-3-13-26-24/h4-6,8-10,15,19,29H,3,7,11-14H2,1-2H3,(H,27,31)(H,32,33)(H2,25,26,28,30)/t19-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Aventis Pharma Deutschland GmbH Curated by ChEMBL					Assay Description Concentration required to reduce binding of Kistrin to Vitronectin receptor (alpha V beta 3) by 50%				Bioorg Med Chem Lett 11: 2011-5 (2001) BindingDB Entry DOI: 10.7270/Q2N87930
					More data for this Ligand-Target Pair
Integrin alpha-V/beta-3 (Homo sapiens (Human))	BDBM50101753 ((S)-2-(4-Isopropyl-benzenesulfonylamino)-3-({5-[2-...) Show SMILES CC(C)c1ccc(cc1)S(=O)(=O)N[C@@H](CNC(=O)c1ccc(CCC(=O)NC2=NCCCN2)s1)C(O)=O |t:28| Show InChI InChI=1S/C24H31N5O6S2/c1-15(2)16-4-8-18(9-5-16)37(34,35)29-19(23(32)33)14-27-22(31)20-10-6-17(36-20)7-11-21(30)28-24-25-12-3-13-26-24/h4-6,8-10,15,19,29H,3,7,11-14H2,1-2H3,(H,27,31)(H,32,33)(H2,25,26,28,30)/t19-/m0/s1	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	6	n/a	n/a	n/a	n/a	n/a	n/a
Aventis Pharma Deutschland GmbH Curated by ChEMBL					Assay Description Concentration required to reduce binding of human 293 cell attachment to immobilized vitronectin receptor(Vn/293) by 50%				Bioorg Med Chem Lett 11: 2011-5 (2001) BindingDB Entry DOI: 10.7270/Q2N87930
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50101753 ((S)-2-(4-Isopropyl-benzenesulfonylamino)-3-({5-[2-...) Show SMILES CC(C)c1ccc(cc1)S(=O)(=O)N[C@@H](CNC(=O)c1ccc(CCC(=O)NC2=NCCCN2)s1)C(O)=O |t:28| Show InChI InChI=1S/C24H31N5O6S2/c1-15(2)16-4-8-18(9-5-16)37(34,35)29-19(23(32)33)14-27-22(31)20-10-6-17(36-20)7-11-21(30)28-24-25-12-3-13-26-24/h4-6,8-10,15,19,29H,3,7,11-14H2,1-2H3,(H,27,31)(H,32,33)(H2,25,26,28,30)/t19-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	17	n/a	n/a	n/a	n/a	n/a	n/a
Aventis Pharma Deutschland GmbH Curated by ChEMBL					Assay Description Concentration required to reduce binding of human 293 cell attachment to immobilized vitronectin receptor(Vn/293) by 50%				Bioorg Med Chem Lett 11: 2011-5 (2001) BindingDB Entry DOI: 10.7270/Q2N87930
					More data for this Ligand-Target Pair